Breast cancer treatment in Ireland is poised for a transformative change starting June 1st, with the Health Service Executive's approval of a new drug, abemaciclib, designed to significantly ...

A combination, triplet therapy that targets cancer cells from within and without caused tumors to shrink or stabilize in ...

Verzenio (abemaciclib) is a CDK4 and 6 inhibitor, and has been approved by the European Commission in women living with HR+, HER2- advanced breast cancer, in combination with an aromatase ...

Adding metformin to letrozole and abemaciclib (Verzenio) was tied to deep responses and prolonged progression-free survival ...

As VERZENIO gains traction in early-stage treatments and broadens its approved uses, its revenue is expected to keep growing. While the globa ...